Peptide derivatives for treatment, prevention or alleviation of a condition associated with bone loss or low bone density or to inhibit osteoclast differentiation and stimulation

US8748370B2 · kind B2 · utility

Assignee

• STRONGBONE AB · SE

Inventors

• Anders Grubb · Lund, SE
• Franciszek Kasprzykowski · Pruszcz Gdański, PL
• Ulf Lerner · Umeå, SE
• Beata Zolnowska · Gdańsk, PL
• Regina Kasprzykowska · Gdańsk, PL

Key dates

• Filing date: Jun 17, 2010
• Grant date: Jun 10, 2014
• Expiry date: Jun 22, 2030

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61K38/00
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Novel compounds which may be for treatment, prevention or alleviation of a condition associated with bone loss or low bone density or to inhibit osteoclast differentiation and stimulation, bone resorption, or loosening of a prosthetic device.